PM360 asked experts in market access and working with payers what innovations to expect ...
We can’t ignore the lessons of the COVID-19 crisis: our healthcare and public health ...
With 71% of voters citing it as their foremost concern, healthcare was among the ...
First, let’s acknowledge the obvious—nobody knows what Trump’s win might mean for the pharma ...
On January 1, 2014, the Affordable Care Act’s (ACA) Exchange Plans will open for ...
Non-Adherence, Technology and DTC A recent study from Capgemini Consulting found that the pharma ...
Evidence-Based Medicine Along with creating an increase in healthcare demand and the subsequent provider ...
Whether you supported it or opposed it, as 2013 unfolds “Obama Care”/ “The Affordable ...
“What would Apple do in this situation?” This may seem like a common question ...
All is finally said and done. Despite some lingering clarifications, the mystery surrounding the ...
In specialty pharma, brand marketers need to integrate distribution with patient services in order ...
In the wake of the Supreme Court’s ruling on the Affordable Care Act, the ...
INDEX ACA–The Right Rx for Pharma and America? ACA–The Physician Perspective: Our Doctors Weigh ...